IL111094A0 - Pharmaceutical compositions comprising a combination of ranitidine and calcium carbonate - Google Patents
Pharmaceutical compositions comprising a combination of ranitidine and calcium carbonateInfo
- Publication number
- IL111094A0 IL111094A0 IL11109494A IL11109494A IL111094A0 IL 111094 A0 IL111094 A0 IL 111094A0 IL 11109494 A IL11109494 A IL 11109494A IL 11109494 A IL11109494 A IL 11109494A IL 111094 A0 IL111094 A0 IL 111094A0
- Authority
- IL
- Israel
- Prior art keywords
- ranitidine
- combination
- pharmaceutical compositions
- calcium carbonate
- carbonate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12951793A | 1993-09-30 | 1993-09-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL111094A0 true IL111094A0 (en) | 1994-11-28 |
Family
ID=22440376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11109494A IL111094A0 (en) | 1993-09-30 | 1994-09-29 | Pharmaceutical compositions comprising a combination of ranitidine and calcium carbonate |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0721338A1 (en) |
| JP (1) | JPH09503212A (en) |
| CN (1) | CN1140996A (en) |
| AU (1) | AU677108B2 (en) |
| BG (1) | BG100456A (en) |
| CA (1) | CA2168846A1 (en) |
| CZ (1) | CZ76996A3 (en) |
| HU (1) | HUT75061A (en) |
| IL (1) | IL111094A0 (en) |
| NO (1) | NO961297D0 (en) |
| NZ (1) | NZ274713A (en) |
| OA (1) | OA10717A (en) |
| PL (1) | PL316855A1 (en) |
| SG (1) | SG44715A1 (en) |
| SK (1) | SK40596A3 (en) |
| WO (1) | WO1995008997A1 (en) |
| ZA (1) | ZA947553B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5560701B2 (en) * | 2008-12-26 | 2014-07-30 | ライオン株式会社 | Ranitidine-containing pharmaceutical solid preparation and method for producing ranitidine-carrying particles |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0482832A (en) * | 1988-09-20 | 1992-03-16 | Glaxo Group Ltd | Pharmaceutical composition |
| WO1992000102A1 (en) * | 1990-06-22 | 1992-01-09 | Beecham Group Plc | Novel treatment |
| GB9127150D0 (en) * | 1991-12-20 | 1992-02-19 | Smithkline Beecham Plc | Novel treatment |
| US5229137A (en) * | 1992-05-06 | 1993-07-20 | Brigham And Women's Hospital, Inc. | Methods and pharmaceutical compositions for treating episodic heartburn |
-
1994
- 1994-09-28 ZA ZA947553A patent/ZA947553B/en unknown
- 1994-09-29 HU HU9600810A patent/HUT75061A/en unknown
- 1994-09-29 CN CN94193540A patent/CN1140996A/en active Pending
- 1994-09-29 IL IL11109494A patent/IL111094A0/en unknown
- 1994-09-29 CA CA002168846A patent/CA2168846A1/en not_active Abandoned
- 1994-09-29 CZ CZ96769A patent/CZ76996A3/en unknown
- 1994-09-29 AU AU79253/94A patent/AU677108B2/en not_active Ceased
- 1994-09-29 SK SK405-96A patent/SK40596A3/en unknown
- 1994-09-29 WO PCT/US1994/011132 patent/WO1995008997A1/en not_active Application Discontinuation
- 1994-09-29 NZ NZ274713A patent/NZ274713A/en unknown
- 1994-09-29 SG SG1996006196A patent/SG44715A1/en unknown
- 1994-09-29 PL PL94316855A patent/PL316855A1/en unknown
- 1994-09-29 EP EP94929984A patent/EP0721338A1/en not_active Withdrawn
- 1994-09-29 JP JP7510481A patent/JPH09503212A/en active Pending
-
1996
- 1996-03-08 OA OA60792A patent/OA10717A/en unknown
- 1996-03-27 BG BG100456A patent/BG100456A/en unknown
- 1996-03-29 NO NO961297A patent/NO961297D0/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU7925394A (en) | 1995-04-18 |
| ZA947553B (en) | 1995-05-26 |
| AU677108B2 (en) | 1997-04-10 |
| HUT75061A (en) | 1997-03-28 |
| OA10717A (en) | 2002-12-09 |
| PL316855A1 (en) | 1997-02-17 |
| WO1995008997A1 (en) | 1995-04-06 |
| CA2168846A1 (en) | 1995-04-06 |
| NZ274713A (en) | 1997-10-24 |
| CZ76996A3 (en) | 1996-10-16 |
| NO961297L (en) | 1996-03-29 |
| EP0721338A1 (en) | 1996-07-17 |
| CN1140996A (en) | 1997-01-22 |
| SG44715A1 (en) | 1997-12-19 |
| HU9600810D0 (en) | 1996-05-28 |
| SK40596A3 (en) | 1997-02-05 |
| NO961297D0 (en) | 1996-03-29 |
| BG100456A (en) | 1996-11-29 |
| JPH09503212A (en) | 1997-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ314376A (en) | Substituted sulphonamides and pharmaceutical compositions | |
| IL113410A0 (en) | Substituted sulfonamides their use and pharmaceutical compositions containing them | |
| ZA947305B (en) | Pharmaceutical compositions and usages | |
| IL111221A0 (en) | N-alkyl-n- arylpyrimidinamine derivatives and pharmaceutical compositions containing them | |
| IL191904A0 (en) | Pharmaceutical and compositions containing a?? fragments | |
| NZ244766A (en) | Bi-aromatic compounds and pharmaceutical compositions | |
| ZA946262B (en) | Pharmaceutical compositions | |
| HK124397A (en) | Terazosin polymorph and pharmaceutical composition | |
| EP0898597A4 (en) | Acid resistant calcium carbonate composition and uses therefor | |
| PL313796A1 (en) | Orally administered composition containing a combination of calcium peroxide and hydrocarbonate | |
| IL118221A0 (en) | Substituted cephalosporins and pharmaceutical compositions containing them | |
| GB9317610D0 (en) | Pharmaceutical compositions | |
| GB9504040D0 (en) | Arylsulfonamide derivative and pharmaceutical composition containing the same | |
| IL98680A0 (en) | Hydroxamate derivatives and pharmaceutical compositions containing them | |
| HK1014137A1 (en) | Benzopyrans and pharmaceutical compositions containing them | |
| IL111094A0 (en) | Pharmaceutical compositions comprising a combination of ranitidine and calcium carbonate | |
| ZA949962B (en) | Ranitidine composition | |
| IL108881A0 (en) | Pharmaceutical compositions containing a combination of verapamil and trandolapril | |
| ZA944769B (en) | Thf-gamma2 analogs and pharmaceutical compositions comprising them | |
| IL111671A0 (en) | Pyrone derivatives and pharmaceutical compositions containing them | |
| IL110336A0 (en) | Pharmaceutical compositions containing a combination of esuprone and levodopa, and their preparation | |
| IL90181A (en) | Pharmaceutical compositions comprising 2-mimetics and paf- antagonists | |
| HU9401771D0 (en) | Pharmaceutical compositions cintaining ipsapiron | |
| GB9301251D0 (en) | Pharmaceutical compositions and use therefor | |
| IL105261A0 (en) | Hydroxamates and pharmaceutical compositions comprising them |